Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Ondansetron in treatment of schizophrenia.

× No keyword cloud information.

7 in total

Review 1. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.

Authors: A J Greenshaw; P H Silverstone
Journal: Drugs Date: 1997-01 Impact factor: 9.546

Review 2. Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.

Authors: B K Young; R Camicioli; L Ganzini
Journal: Drugs Aging Date: 1997-05 Impact factor: 3.923

3. Clozapine's antipsychotic effects do not depend on blockade of 5-HT3 receptors.

Authors: R F Squires; E Saederup
Journal: Neurochem Res Date: 1999-05 Impact factor: 3.996

Review 4. Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors: M I Wilde; A Markham
Journal: Drugs Date: 1996-11 Impact factor: 9.546

5. The effect of a 5-HT3 receptor antagonist, ondansetron, on brain stimulation reward, and its interaction with direct and indirect stimulants of central dopaminergic transmission.

Authors: A M Montgomery; I C Rose; L J Herberg
Journal: J Neural Transm Gen Sect Date: 1993

Review 6. Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.

Authors: R M Hagan; G J Kilpatrick; M B Tyers
Journal: Psychopharmacology (Berl) Date: 1993 Impact factor: 4.530

7. A placebo-controlled study of tropisetron added to risperidone for the treatment of negative symptoms in chronic and stable schizophrenia.

Authors: Maryam Noroozian; Sina Ghasemi; Seyed-Mohammad-Reza Hosseini; Amirhossein Modabbernia; Mohammad-Reza Khodaie-Ardakani; Omid Mirshafiee; Mehdi Farokhnia; Masih Tajdini; Farzin Rezaei; Bahman Salehi; Mandana Ashrafi; Habibeh Yekehtaz; Mina Tabrizi; Shahin Akhondzadeh
Journal: Psychopharmacology (Berl) Date: 2013-03-21 Impact factor: 4.530

7 in total